Bain Capital Life Sciences Opportunities III LP 13D and 13G filings for Disc Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:44 pm Purchase | 2024-09-30 | 13G | Disc Medicine, Inc. IRON | Bain Capital Life Sciences Opportunities III LP | 1,795,735 6.000% | 463,190 (+34.76%) | Filing |
| 2024-02-13 6:51 pm Sale | 2023-12-31 | 13G | Disc Medicine, Inc. IRON | Bain Capital Life Sciences Opportunities III LP | 1,332,545 5.500% | -658,369 (-33.07%) | Filing |
| 2023-02-24 4:45 pm Purchase | 2023-02-15 | 13G | Disc Medicine, Inc. IRON | Bain Capital Life Sciences Opportunities III LP | 1,990,914 9.990% | 1,990,914 (New Position) | Filing |